![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
News
Avid Bioservices, Argonaut Enter Manufacturing Services Pact
Avid Bioservices, Inc., a biologics CDMO, and Argonaut Manufacturing Services, a cGMP contract manufacturing organization (CMO) have entered a co-marketing agreement to provide an...
Press Releases
Thermo Fisher Scientific and Lyell Immunopharma Form Cell Therapy Manufacturing Partnership
Thermo Fisher Scientific Inc., the world leader in serving science, and biotechnology company Lyell Immunopharma, are partnering to develop manufacturing processes designed to create...
Press Releases
FUJIFILM Diosynth Biotechnologies Texas Facility to Support COVID-19 Vaccine Candidate Manufacturing
FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene therapies, announced that its College Station,...
News
Abzena receives growth capital investment from newly launched Biospring Partners
Abzena, a leading global partnership research organization providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs), has announced a $10M...
Press Releases
Sterling Signs Deal to Produce Potential COVID-19 Drug Candidate for Moleculin
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions has signed an agreement with Moleculin Biotech, Inc., to support the company’s expanded development...
News
CPhI Japan rescheduled for Spring 2021 with digital solutions to be launched
CPhI Japan organised by Informa Markets announces that, following a detailed review with partners and key industry stakeholders and to ensure the health and...
Press Releases
Cipla receives regulatory approval for launch of Ciplenza (Favipiravir 200 mg) in India to treat mild to moderate COVID-19
Cipla Limited announced that it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
